Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jose M Pego-Reigosa"'
Autor:
Carlos Rafael-Vidal, Irene Altabás, Nair Pérez, Coral Mourino Rodríguez, Jose M. Pego-Reigosa, Samuel Garcia
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 3, p 1263 (2021)
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a broad spectrum of clinical presentations that can affect almost all organ systems. Lupus nephritis (LN) is a severe complication that affects approximately half of the systemic
Externí odkaz:
https://doaj.org/article/b253937eac9a4e1badb17bc40c2f68fc
Autor:
Tiago Carvalheiro, Ana P. Lopes, Maarten van der Kroef, Beatriz Malvar-Fernandez, Carlos Rafael-Vidal, Anneline C. Hinrichs, Nila H. Servaas, Femke Bonte-Mineur, Marc R. Kok, Lorenzo Beretta, Maili Zimmermann, Wioleta Marut, Jose M. Pego-Reigosa, Timothy R. D. J. Radstake, Samuel Garcia
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 24, p 9544 (2020)
Angiopoietin-2 (Ang-2), a ligand of the tyrosine kinase receptor Tie2, is essential for vascular development and blood vessel stability and is also involved in monocyte activation. Here, we examined the role of Ang-2 on monocyte activation in patient
Externí odkaz:
https://doaj.org/article/d20f2409f26e4b589add05d5ec117d02
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 19, p 7100 (2020)
Systemic rheumatic diseases are a heterogeneous group of autoimmune disorders that affect the connective tissue, characterized by the involvement of multiple organs, leading to disability, organ failure and premature mortality. Despite the advances i
Externí odkaz:
https://doaj.org/article/d520115d5e4049e3bf1699f5aaacd4c0
Autor:
Tiago Carvalheiro, Carlos Rafael-Vidal, Beatriz Malvar-Fernandez, Ana P. Lopes, Jose M. Pego-Reigosa, Timothy R. D. J. Radstake, Samuel Garcia
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 18, p 6965 (2020)
Semaphorin (Sema)4A is a transmembrane glycoprotein that is elevated in several autoimmune diseases such as systemic sclerosis, rheumatoid arthritis and multiple sclerosis. Sema4A has a key role in the regulation of Thelper Th1 and Th2 differentiatio
Externí odkaz:
https://doaj.org/article/d28363f672f64809bbf8ea75daf5aaaa
Autor:
Ana Igea, Tiago Carvalheiro, Beatriz Malvar‐Fernández, Sara Martinez‐Ramos, Carlos Rafael‐Vidal, Ellis Niemantsverdriet, Jezabel Varadé, Andrea Fernández‐Carrera, Norman Jimenez, Trudy McGarry, Angela Rodriguez‐Trillo, Douglas Veale, Ursula Fearon, Carmen Conde, Jose M. Pego‐Reigosa, África González‐Fernández, Kris A. Reedquist, Timothy R. D. J. Radstake, Annette Helm‐Van Mil, Samuel García
Publikováno v:
Arthritis & Rheumatology, 74(6), 972-983. WILEY
Arthritis and Rheumatology, 74(6), 972-983. John Wiley & Sons Ltd.
Arthritis and Rheumatology, 74(6), 972-983. John Wiley & Sons Ltd.
Objective: Semaphorin 3B (Sema3B) decreases the migratory and invasive capacities of fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA) and suppresses expression of matrix metalloproteinases. We undertook this study to examine the role o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50bed92ce4cedda1a78568ee213edaaa
http://hdl.handle.net/1887/3458791
http://hdl.handle.net/1887/3458791
Autor:
Carlos Montilla, Paloma Vela, Íñigo Rúa-Figueroa, José M Pego-Reigosa, Karen Roberts, Javier Narváez, Raúl Menor-Almagro, Alejandro Olivé, María Galindo, Antonio Fernández-Nebro, Eva Tomero, Julia Martínez-Barrio, Javier Manero, Gema Bonilla, Elena Aurrecoechea, María Jesús García-Villanueva, Eva Salgado, Mercedes Freire-González, Vicenç Torrente-Segarra, Jaime Calvo Alen, Victor Del Campo Perez, Gregorio Santos Soler, Cristina Bohorquez, Irene Altabás-González, Norman Jimenez, Coral Mouriño, Nuria Lozano-Rivas, Ana Paula Cacheda, Esther Uriarte Itzazelaia, Víctor Martínez Taboada, José Ángel Hernández-Beriain, Oihane Ibarguengoitia-Barrena, Claudia Moriano-Morales, Concepción Fito Manteca
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 2 (2024)
Objective To assess organ damage, with emphasis on the cardiovascular system, over the different stages of the disease in a large SLE cohort.Methods Multicentre, longitudinal study of a cohort of 4219 patients with SLE enrolled in the Spanish Society
Externí odkaz:
https://doaj.org/article/42e97bb600214c62acc73fb4641feb12
Autor:
Rubén Varela-Calviño, Carlos Rafael-Vidal, Oscar J. Cordero, Samuel Garcia, Beatriz Malvar-Fernández, Juan E. Viñuela, Jose M Pego-Reigosa, Cristina Calviño-Sampedro
Publikováno v:
Biomolecules
Volume 11
Issue 10
Biomolecules, Vol 11, Iss 1446, p 1446 (2021)
Volume 11
Issue 10
Biomolecules, Vol 11, Iss 1446, p 1446 (2021)
Immune system CD4 T-cells with high cell-surface CD26 expression show anti-tumoral properties. When engineered with a chimeric antigen receptor (CAR), they incite strong responses against solid cancers. This subset was originally associated to human
Autor:
Jose M Pego-Reigosa, María Luísa De Castro-Parga, Daniel González-Vilas, Amelia Cibeira-Badia, María Guadalupe Piñeiro-Corrales, Nerea García-Beloso, Ángel Salgado-Barreira, Irene Altabás-González, Mónica Gayoso-Rey, Marisol Samartín-Ucha, Noemí Martínez-López de Castro
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(4)
Aims Adalimumab is a biological therapy used to treat different chronic inflammatory diseases. At present, there is an increasing number of adalimumab biosimilars. To assume the acceptability of interchangeability between reference adalimumab and bio
Autor:
Jose María Álvaro Gracia, Carlos Sanchez-Piedra, Javier Manero, María Ester Ruiz-Lucea, Laura López-Vives, Cristina Bohorquez, Julia Martinez-Barrio, Gema Bonilla, Paloma Vela, María Jesús García-Villanueva, María Teresa Navío-Marco, Marina Pavía, María Galindo, Celia Erausquin, Miguel A Gonzalez-Gay, Inigo Rua-Figueroa, Jose M Pego-Reigosa, Isabel Castrejon, Jesús T Sanchez-Costa, Enrique González-Dávila, Federico Diaz-Gonzalez
Publikováno v:
RMD Open
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
RMD Open . 2021 Dec;7(3):e001925.
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
RMD Open . 2021 Dec;7(3):e001925.
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
ObjectivesTo analyse the effect of targeted therapies, either biological (b) disease-modifying antirheumatic drugs (DMARDs), targeted synthetic (ts) DMARDs and other factors (demographics, comorbidities or COVID-19 symptoms) on the risk of COVID-19 r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c8a315ceb67ad45d298da3b8ceabde
http://zaguan.unizar.es/record/112477
http://zaguan.unizar.es/record/112477
Autor:
Jose M Pego-Reigosa, Coral Mourino Rodríguez, Irene Altabás, Nair Pérez, Carlos Rafael-Vidal, Samuel Garcia
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 1263, p 1263 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a broad spectrum of clinical presentations that can affect almost all organ systems. Lupus nephritis (LN) is a severe complication that affects approximately half of the systemic